BPA Call 15B41420A00000001-15B41421F00000148
- This is a Blanket Purchase Agreement (BPA) call order awarded by the Medical Center for Federal Prisoners Springfield, a civilian federal agency, to Roche Diagnostics Corporation. The contract is for the lease of chemistry and immunochemistry analyzers and the supply of associated reagents for the period of July through September 2021. The contract has a ceiling value of $238,296.63 and is classified under the Critical Analyzers, Laboratory (FSS-66-III) GSA Schedule. The contract does not have a...
- The U.S. Federal Government awarded a Blanket Purchase Agreement (BPA) call order to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, for the provision of lease and installation of chemistry and immunochemistry analyzers at the United States Medical Center for Federal Prisoners (USMCFP) in Springfield, Missouri. The contract, with a ceiling value of $129,665.58, is under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule and has a...
- This is a firm fixed-price Blanket Purchase Agreement (BPA) call award by the Medical Center for Federal Prisoners Springfield, a civilian agency, to Roche Diagnostics Corporation, a foreign-owned for-profit manufacturer of in vitro diagnostics, reagents, and laboratory instruments. The $15,171.80 award is for the second quarter of fiscal year 2025 to provide the agency with a Roche chemical analyzer. The contract is a call against Roche's existing General Services Administration (GSA)...
- This contract modification adds $64,285.98 in funding to an existing Blanket Purchase Agreement (BPA) call for Roche chemical analyzer equipment and supplies. Roche Diagnostics Corporation, a foreign-owned manufacturer of in vitro diagnostics and laboratory instruments, is the awardee under this firm fixed-price contract with the Medical Center for Federal Prisoners Springfield, a civilian federal healthcare facility. The work is to be performed in Castleton, Indiana, with an ultimate completion...
- The U.S. government has awarded a firm-fixed-price Blanket Purchase Agreement (BPA) call contract to Roche Diagnostics Corporation, a manufacturer of in vitro diagnostics and laboratory equipment. The contract, valued at $185,630.57, is for the provision of a lease and installation of chemistry and immunochemistry analyzers at the United States Medical Center for Federal Prisoners (USMCFP) in Springfield, Missouri. This requirement is under the Critical Analyzers, Laboratory (FSS-66-III)...
- Roche Diagnostics Corporation received a Blanket Purchase Agreement (BPA) call award valued at $40,000 from the Medical Center for Federal Prisoners Springfield, a civilian federal healthcare facility. The contract, awarded on February 1, 2026, with an ultimate completion date of March 31, 2026, covers a Roche chemical analyzer and related services. This award is a child contract under the General Services Administration's Critical Analyzers, Laboratory (FSS-66-III) schedule, which establishes...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the provision of lease and installation of chemistry and immunochemistry analyzer equipment at the United States Medical Center for Federal Prisoners (USMCFP) in Springfield, Missouri. The 3-month contract, with a ceiling value of $150,154.58, was awarded on October 1, 2022 and has a completion date of December 31, 2022. The contract is a Blanket Purchase Agreement (BPA) call off of...
- The federal contract award is for a Blanket Purchase Agreement (BPA) call for reagents, a lease of chemistry and immunochemistry analyzers, and associated laboratory equipment, supplies, and services from Roche Diagnostics Corporation. The $238,296.63 contract, which does not have a set-aside designation, was awarded by the Medical Center for Federal Prisoners Springfield, which is a civilian agency. The contract is under the General Services Administration (GSA) Schedule for Critical Analyzers,...
- This federal contract award to Roche Diagnostics Corporation, doing business as Roche Diagnostics Corp, is for the provision of lease and installation of chemistry and immunochemistry analyzers at the United States Medical Center for Federal Prisoners (USMCFP) in Springfield, Missouri. The contract is a Blanket Purchase Agreement (BPA) Call, with a firm fixed price of $151,089.36 and a performance period ending on March 31, 2023. The award is not set aside for any specific business category....
- This federal contract award is for the provision of lease and installation of chemistry and immunochemistry analyzers at the United States Medical Center for Federal Prisoners (USMCFP) in Springfield, Missouri. The contract has a ceiling value of $163,865.48 and is a Blanket Purchase Agreement (BPA) call against a General Services Administration (GSA) Schedule contract for Critical Analyzers, Laboratory (FSS-66-III). The prime contractor is Roche Diagnostics Corporation, a manufacturer of in...
- Critical Analyzers, Laboratory (FSS-66-III)Master GSA Schedule
- V797D70105-15B41420A00000001Blanket Purchase Agreement
- 15B41420A00000001-15B41421F00000148BPA Call
This is a Blanket Purchase Agreement (BPA) call issued by the Medical Center for Federal Prisoners Springfield, a civilian agency, for the lease of chemistry and immunochemistry analyzers and the provision of associated reagents during October, November, and December 2021. The prime contractor is Roche Diagnostics Corporation, a foreign-owned, for-profit manufacturer of in vitro diagnostics, laboratory instruments, and medical equipment. The contract has a ceiling value of $144,537.05 and no set-aside designation. Roche Diagnostics has experience as both a prime contractor and subcontractor, providing a wide range of medical equipment, supplies, and laboratory services to various federal agencies, including the Department of Veterans Affairs, Department of Defense, and Department of Health and Human Services, through GSA Schedule contracts and other indefinite delivery vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| A00004 | Funding Only Action | ($5k) | 4/1/22 | |
| A00003 | Funding Only Action | $30.0k | 12/22/21 | |
| A00002 | Funding Only Action | $20.0k | 12/2/21 | |
| A00001 | Funding Only Action | $100.0k | 11/5/21 | |
| Not listed | Not listed | $0 | 9/3/21 |